Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 07.11.2024
Achieve Life Sciences Мультипликаторы 2011-2024 | ACHV
Мультипликаторы по годам Achieve Life Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.0 | -1.1 | -1.9 | -1.5 | -0.3 | -0.4 | -0.7 | -0.8 | -1.0 | -1.4 | -5.0 | -8.5 | -9.2 |
P/S |
- | - | - | - | - | - | - | 3.2 | 1.0 | 1.3 | 5.4 | 8.9 | 24.6 |
EPS |
-1.5 | -4 | -4.1 | -5.4 | -39.8 | -72.3 | -22.1 | -581.2 | -39 | -1.4 | -2.2 | -1.6 | -1.5 |
EV (Enterprise Value) |
95.5 млн | 45.1 млн | 39.6 млн | -10.8 млн | -9.1 млн | -1.11 млн | 4.35 млн | 9.44 млн | 3.72 млн | 30.7 млн | 165 млн | 178 млн | 144 млн |
EBITDA per Share |
0.01 | 0.02 | 0.03 | 0.09 | -39.5 | -71.4 | 35 | -1.36 тыс. | -1.56 тыс. | -3.59 тыс. | -5.26 тыс. | -4.48 тыс. | -5.02 тыс. |
EV/EBITDA |
1233.0 | 2.1 | 0.7 | 0.4 | 2.8 | -0.1 | 0.9 | -0.3 | -4.2 | -5.9 | -4.8 | ||
PEG |
0.05 | 0.01 | 0.02 | 0.01 | -0.01 | -0.0 | -0.01 | 0.17 | -0.02 | -0.04 | 0.13 | 2.57 | -0.59 |
P/B |
-62.3 | 5.8 | 2.3 | 0.6 | 0.3 | 0.3 | 1.0 | 0.9 | 0.5 | 1.1 | 4.3 | 2.7 | 4.4 |
P/CF |
-3.7 | -1.3 | -2.1 | -1.6 | -0.3 | -0.5 | -0.8 | -0.5 | -1.8 | -2.1 | -4.4 | -4.1 | -6.6 |
ROE % |
2059.05 | -510.06 | -118.22 | -39.51 | -90.83 | -80.29 | -134.32 | -106.13 | -44.87 | -77.04 | -85.59 | -31.87 | -47.50 |
ROA % |
-153.92 | -141.30 | -69.77 | -36.55 | -77.78 | -66.48 | -106.99 | -73.28 | -28.86 | -46.61 | -57.19 | -25.72 | -21.57 |
ROCE % |
- | - | - | - | -90.77 | -81.02 | -84.17 | -98.13 | -49.95 | -87.26 | -86.68 | -39.23 | -59.86 |
Current Ratio |
0.9 | 1.4 | 2.4 | 13.4 | 6.0 | 4.8 | 2.9 | 3.2 | 2.8 | 2.5 | 3.6 | 6.9 | 2.2 |
DSO |
- | - | - | - | - | - | - | 36.8 | 2.5 | 77.9 | 108.4 | 18.9 | 53.9 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Achieve Life Sciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.36 | -0.25 | -0.26 | - | -0.34 | -0.43 | -0.5 | - | -1.35 | -1.08 | -0.8 | -0.76 | -0.71 | -1.53 | -1.3 | -1.11 | -1.14 | -1.68 | -2.15 | -5.91 | -9.07 | -10.08 | -17.57 | -0.55 | -0.71 | -1.82 | -2.43 | -3.17 | -8.95 | -79.6 | -96.56 | -22.89 | -12.62 | -11.21 | -11.4 | 0.06 | 0.16 | 0.26 | 0.2 | -0.26 | -0.23 | -0.47 | -0.59 | -0.45 | -0.68 | -0.57 | -0.46 | -0.28 | 0.4 | -0.29 | -0.67 | -0.98 | -0.46 | -0.67 | -0.31 |
EBITDA per Share |
- | - | - | - | - | - | - | - | 0.01 | 0.01 | 0.01 | - | 0.02 | 0.02 | 0.01 | - | 0.06 | 0.07 | 0.04 | - | 0.47 | 0.36 | 0.01 | - | 0.05 | 0.1 | 0.07 | - | 0.26 | 52.3 | 2.64 | - | 7.82 | - | - | - | 0.01 | - | - | - | 0.01 | 0.01 | - | - | 0.01 | 0.01 | - | - | 0.57 | 0.41 | -0.37 | - | 0.43 | 0.52 | -0.53 |
ROE % |
-249.04 | -385.20 | -450.13 | -2290.77 | -3543.36 | -4619.92 | -4614.48 | -1367.43 | -1392.93 | -159.62 | -107.80 | -99.06 | -86.22 | -77.04 | -57.19 | -39.51 | -44.53 | -54.79 | -67.03 | -90.83 | -96.15 | -96.31 | -93.87 | -80.29 | -80.94 | -142.54 | -127.04 | -110.52 | -166.52 | -128.35 | -127.46 | -126.14 | -140.05 | -108.27 | -123.07 | -133.86 | -56.95 | -59.21 | -63.75 | -77.04 | -78.31 | -90.92 | -92.95 | -85.59 | -73.84 | -55.76 | -39.50 | -31.87 | -56.64 | -33.23 | -48.00 | -47.50 | 14.47 | -21.14 | -9.86 |
ROA % |
-77.65 | -80.75 | -96.18 | -100.94 | -156.06 | -181.98 | -184.28 | -104.57 | -119.62 | -82.20 | -76.22 | -81.34 | -78.01 | -69.65 | -52.08 | -36.55 | -39.98 | -48.07 | -58.01 | -77.78 | -81.69 | -81.24 | -78.65 | -66.48 | -85.23 | -133.65 | -120.75 | -106.99 | -81.94 | -23.59 | -22.74 | -21.55 | -11.75 | -12.52 | -21.98 | -28.86 | -36.00 | -36.90 | -39.03 | -46.61 | -48.51 | -57.85 | -60.51 | -57.19 | -50.20 | -39.37 | -29.39 | -25.72 | -34.79 | -21.00 | -25.46 | -21.57 | 6.57 | -9.60 | -4.48 |
ROCE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.52 | 25.04 | 34.02 | 13.19 | 26.45 | 27.19 | 34.38 | 12.51 | 13.26 | 16.16 | -16.91 |
Current Ratio |
2.9 | 2.9 | 3.4 | 0.9 | 1.2 | 1.5 | 1.0 | 1.4 | 1.1 | 1.6 | 2.1 | 2.4 | 12.2 | 9.7 | 9.4 | 13.4 | 13.4 | 13.4 | 13.4 | 7.0 | 7.0 | 7.0 | 7.0 | 5.8 | 5.8 | 5.8 | 5.8 | 4.9 | 4.9 | 4.9 | 4.9 | 1.2 | 1.2 | 3.2 | 3.2 | 2.8 | 2.8 | 2.8 | 2.8 | 2.5 | 2.5 | 2.5 | 2.5 | 3.0 | 3.0 | 3.0 | 3.0 | 5.2 | 5.2 | 5.2 | 5.2 | 1.8 | 1.8 | 1.8 | 1.8 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD